A case of pigmentary retinopathy attributed to an oral contraceptive is described. After suspension of the drug the ocular symptoms regressed, whereas the ophthalmoscopic and fluorescein angiographic picture did not reflect this regression. Fluorescein angiography, used in this condition for the first time, showed that the amount of pigment was much greater than that observed ophthalmo-scopically.
PIP: This is a case report of a 20-year-old woman who had used an oral contraceptive (EVANOR-d) for 6 months before she complained of a sudden blurring of vision in the right eye. Visual acuity did not degenerate, and ophthalmoscopic examination revealed no abnormal findings in the left eye but pigmentary mottling in the macula of the right eye was visualized. Retinal fluorscein angiograph showed that the amount of pigment was even greater than seen ophthalmoscopically. The oral contraceptive was stopped, and the ocular symptoms regressed, but the ophthalmoscopic and fluorescein angiographic picture did not reflect this regression.